506879 — Gujarat Themis Biosyn Income Statement
0.000.00%
Last trade - 00:00
- IN₹28.03bn
- IN₹28.00bn
- IN₹1.49bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 410 | 851 | 906 | 1,149 | 1,490 |
Cost of Revenue | |||||
Gross Profit | 165 | 738 | 752 | 982 | 918 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 349 | 546 | 520 | 590 | 773 |
Operating Profit | 61.1 | 305 | 386 | 558 | 716 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 82 | 313 | 409 | 590 | 775 |
Provision for Income Taxes | |||||
Net Income After Taxes | 64.1 | 237 | 302 | 436 | 580 |
Net Income Before Extraordinary Items | |||||
Net Income | 64.1 | 237 | 302 | 436 | 580 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 64.1 | 237 | 302 | 436 | 580 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.882 | 3.26 | 4.15 | 6.01 | 7.98 |
Dividends per Share |